Cargando…

Lymphatic Dysfunction as a Novel Therapeutic Target in Nonalcoholic Steatohepatitis

Detalles Bibliográficos
Autores principales: Jeong, Jain, Iwakiri, Yasuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846486/
https://www.ncbi.nlm.nih.gov/pubmed/33220266
http://dx.doi.org/10.1016/j.jcmgh.2020.10.013
_version_ 1783644741760450560
author Jeong, Jain
Iwakiri, Yasuko
author_facet Jeong, Jain
Iwakiri, Yasuko
author_sort Jeong, Jain
collection PubMed
description
format Online
Article
Text
id pubmed-7846486
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-78464862021-02-04 Lymphatic Dysfunction as a Novel Therapeutic Target in Nonalcoholic Steatohepatitis Jeong, Jain Iwakiri, Yasuko Cell Mol Gastroenterol Hepatol Editorial Elsevier 2020-11-18 /pmc/articles/PMC7846486/ /pubmed/33220266 http://dx.doi.org/10.1016/j.jcmgh.2020.10.013 Text en © 2021 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Editorial
Jeong, Jain
Iwakiri, Yasuko
Lymphatic Dysfunction as a Novel Therapeutic Target in Nonalcoholic Steatohepatitis
title Lymphatic Dysfunction as a Novel Therapeutic Target in Nonalcoholic Steatohepatitis
title_full Lymphatic Dysfunction as a Novel Therapeutic Target in Nonalcoholic Steatohepatitis
title_fullStr Lymphatic Dysfunction as a Novel Therapeutic Target in Nonalcoholic Steatohepatitis
title_full_unstemmed Lymphatic Dysfunction as a Novel Therapeutic Target in Nonalcoholic Steatohepatitis
title_short Lymphatic Dysfunction as a Novel Therapeutic Target in Nonalcoholic Steatohepatitis
title_sort lymphatic dysfunction as a novel therapeutic target in nonalcoholic steatohepatitis
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846486/
https://www.ncbi.nlm.nih.gov/pubmed/33220266
http://dx.doi.org/10.1016/j.jcmgh.2020.10.013
work_keys_str_mv AT jeongjain lymphaticdysfunctionasanoveltherapeutictargetinnonalcoholicsteatohepatitis
AT iwakiriyasuko lymphaticdysfunctionasanoveltherapeutictargetinnonalcoholicsteatohepatitis